GGrantIndex
← Search

DCR Extramural Severable funding of core clinical research infrastructure in support of Ebola and other EID research.

$24,833,950N01FY2018CANIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

This funding supports core clinical research infrastructure to facilitate a broad array of clinical trials on emerging and re-emerging infectious diseases, including Ebola, HIV, tuberculosis, febrile illnesses, influenza, and Zika.

View original record on NIH RePORTER →